Quinazoline derivatives, compositions, and uses related thereto

Philippe Nakache, Omri Erez, Quinazolin-4(3a)-one derivatives and methods of use thereof ,(2010)

David Scott Goldfarb, Method for altering the lifespan of eukaryotic organisms ,(2008)

Eduard Sergienko, Jose Luis Millan, Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification ,(2008)

David M. Weiner, Mark R. Brann, Use of n-desmethylclozapine to treat human neuropsychiatric disease ,(2004)

William K. Hagmann, Malcolm Maccoss, Charles G. Caldwell, Shrenik K. Shah, Karla L. Furman, Kothandaraman Shankaran, Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases Official Gazette of the United States Patent and Trademark Office Patents. ,(1996)

Alfonso R. Gennaro, Remington: The Science and Practice of Pharmacy ,(2003)

Howard C. Ansel, Loyd V. Allen, Nicholas G. Popovich, Pharmaceutical Dosage Forms and Drug Delivery Systems ,(1997)

Wolfram Dr.Med.Vet. Dr.Med.Vet.Habil. Raake, Thomas Dipl. Chem. Dr. Rer. Nat. Pill, Peter Dr. Med. Vet. Zeiller, Rainer Dipl. Chem. Dr. Rer. Nat. Klauser, Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics ,(1994)

Vincent Jaquet, Julien Marcoux, Eric Forest, Kevin G Leidal, Sally McCormick, Yvonne Westermaier, Remo Perozzo, Olivier Plastre, Laetitia Fioraso‐Cartier, Becky Diebold, Leonardo Scapozza, William M Nauseef, Franck Fieschi, Karl‐Heinz Krause, Karen Bedard, NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action British Journal of Pharmacology. ,vol. 164, pp. 507- 520 ,(2011) , 10.1111/J.1476-5381.2011.01439.X

Richard B. Silverman, The Organic Chemistry of Drug Design and Drug Action ,(1992)